查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1587418

美國藥品分析測試外包市場規模、佔有率、趨勢分析報告：按服務、最終用途、地區和細分市場預測，2025-2030 年

U.S. Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report By Services, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

美國藥物分析測試外包市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，美國藥品分析測試外包市場規模預計將達50.9億美元。

預計2025年至2030年該市場將以8.5%的複合年成長率擴張。醫療保健產業的技術進步和最終用戶數量的增加是推動美國市場成長的主要因素。

藥物分析業務，業務使他們能夠專注於自己的核心能力。醫療機構可以避免開發專門設施和僱用員工，從而節省成本。藥物分析測試涉及藥品和治療溶液中成分的識別和測量。由於研發投資增加和藥品需求增加，預計市場在評估期內將擴大。

藥物分析測試外包受到了 COVID-19 疫情的嚴重影響。藥物分析服務是醫療保健基礎設施的重要組成部分，最初由於各製藥公司內部實驗室的測試能力減少或關閉而受到干擾。工作人員最初面臨多項挑戰，包括因擔心病毒傳播而導致實驗室能力下降、IT 問題以及發送樣本進行測試困難等。然而，公司已經採取了各種策略來減少或防止這些困難，例如輪班、縮小規模和在家工作。

多家公司透過創建各種尖端測試和解決方案來支持政府遏制 COVID-19 大流行的努力。這些公司能夠減少 COVID-19對其營運的影響。例如，Eurofins Laboratories 已成功生產了 4,000 萬份 COVID-19檢測套組。此外，正在為不同的變體建立新的檢測套組。當 WHO 將 COVID-19 列為值得關注的變體時，我們當天發布了 Omicron檢測套組。

美國藥物分析測試外包市場報告重點：

  • 隨著生物製藥行業的公司擴大在研發上投入資金並更喜歡外包分析測試，到 2024 年，生物分析測試行業將以 52.2% 的收入佔有率佔據市場主導地位。
  • 在方法開發和驗證領域，2024年提取和浸出服務佔細分市場佔有率為23.55%。
  • 2024年，製藥公司細分市場佔比最大，為45.61%。有關體外和體內測試、先進技術和降低測試複雜性的創新方法的不斷變化的法規是推動藥物分析測試服務外包增加的一些因素。
  • West Pharmaceutical Services, Inc.、SGS SA、Eurofins Scientific、Pace Analytical Services Llc、Intertek Group Plc 是推動市場成長的主要企業。
  • 按最終用途分類，由於臨床試驗註冊和市場進入數量的增加，生物製藥公司預計將在預測期內實現最快的成長。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章美國藥物分析測試外包市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 美國藥品分析測試外包市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • COVID-19 影響分析

第4章美國藥品分析測試外包市場：服務估算與趨勢分析

  • 美國藥物分析測試外包市場，依服務分類：細分儀表板
  • 美國藥物分析測試外包市場，依服務分類：變異分析
  • 按服務分類，2018-2030
  • 生物分析測試
    • 生物分析測試市場，2018-2030
    • 臨床
    • 非臨床
  • 方法開發和檢驗
    • 方法開發與檢驗市場，2018-2030
    • 可萃取和可浸出
    • 雜質法
    • 技術諮詢
    • 其他方法檢驗服務
  • 穩定性測試
    • 穩定性測試市場，2018-2030
    • 藥物成分
    • 穩定性指標檢驗
    • 加速穩定性測試
    • 光穩定性測試
    • 其他穩定性測試方法
  • 其他檢測服務
    • 其他測試服務市場，2018-2030

第5章美國藥物分析測試外包市場：最終用途估算與趨勢分析

  • 美國藥物分析測試外包市場，依最終用途：細分儀表板
  • 按最終用途分類的美國藥物分析測試外包市場：變化分析
  • 按最終用途分類，2018-2030
  • 製藥公司
  • 生物製藥公司
  • 合約調查機構

第6章 競爭狀況

  • 市場參與企業分類
    • 創新者
    • 市場領導者
    • 新興企業
    • 2024 年企業市場佔有率分析
  • 公司簡介
    • West Pharmaceutical Services, Inc.
    • SGS SA
    • Eurofins Scientific
    • Pace Analytical Services Llc
    • Intertek Group PLC
    • Pharmaceutical Product Development, LLC.
    • Wuxi Apptec, Inc.
    • Boston Analytical
    • Charles River Laboratories International, Inc.
Product Code: GVR-4-68039-189-7

U.S. Pharmaceutical Analytical Testing Outsourcing Market Growth & Trends:

The U.S. pharmaceutical analytical testing outsourcing market size is expected to reach USD 5.09 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 8.5% from 2025 to 2030. Technological advancements in the healthcare industry and an increase in end-users are the key factors driving the growth of the U.S. market.

Analytical testing services outsourcing allows companies to handle more complex or repetitive tasks while also assisting companies in concentrating on their core competencies. Enabling medical organizations to avoid developing specialized facilities and hiring staff, results in cost savings. The identification and measurement of ingredients in drugs or therapeutic solutions are included in pharmaceutical analytical testing. The market is anticipated to expand during the assessment period as a result of rising R&D investments and rising drug demand.

The outsourcing of pharmaceutical analytical testing has been significantly impacted by the COVID-19 pandemic. Due to various pharmaceutical companies' internal lab testing capacities being reduced or shut down, the pharmaceutical analytical services-an important component of the healthcare infrastructure-were initially disrupted. The workers initially faced several difficulties, including reduced lab capacity because of concerns about spreading the virus, IT issues, and difficulties sending samples for testing. However, various strategies, including rotating shifts, reducing manpower, and working from home, have been adopted by companies to mitigate or prevent these difficulties.

Various companies supported the government's efforts to stop the COVID-19 pandemic by producing various cutting-edge tests and solutions. These businesses were able to reduce the effects of COVID-19 on their operations. For example, 40 million COVID-19 tests were successfully manufactured by Eurofins laboratories. Additionally, new test kits are being created for various variants. When WHO classified it as a variant of concern, they released an omicron test kit the same day.

U.S. Pharmaceutical Analytical Testing Outsourcing Market Report Highlights:

  • The bioanalytical testing segment dominated the market with a revenue share of 52.2% in 2024 due to players in the biopharmaceutical industry spending money on R&D and a growing preference for outsourcing analytical testing.
  • By method development and validation segment, the extractable and leachable services held 23.55% segment share in 2024.
  • The pharmaceutical companies segment accounted for the largest share of 45.61% in 2024. Changing regulations for in vitro and in vivo tests, sophisticated technologies, and creative methods to reduce test complexity are some of the factors that are causing more pharmaceutical analytical testing services to be outsourced.
  • West Pharmaceutical Services, Inc., SGS SA, Eurofins Scientific, Pace Analytical Services Llc, and Intertek Group Plc are some of the major key players contributing to the growth of the market.
  • Based on end-user, biopharmaceutical companies are anticipated to register the fastest growth over the forecast period due to an increase in the number of clinical trial registrations and market entrants.

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Services
    • 1.2.2. End Use
  • 1.3. Regional Scope
  • 1.4. Estimates And Forecast Timeline
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information Or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
    • 1.9.2. Parent Market Analysis
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Pharmaceutical Analytical Testing Outsourcing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing innovation in testing services
      • 3.2.1.2. Growing regulation, safety & quality requirements
      • 3.2.1.3. Competitive Pricing Strategies
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Data insecurity
      • 3.2.2.2. Third-party performance
  • 3.3. U.S. Pharmaceutical Analytical Testing Outsourcing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. U.S. Pharmaceutical Analytical Testing Outsourcing Market: Services Estimates & Trend Analysis

  • 4.1. U.S. Pharmaceutical Analytical Testing Outsourcing Market, By Services: Segment Dashboard
  • 4.2. U.S. Pharmaceutical Analytical Testing Outsourcing Market, By Services: Movement Analysis
  • 4.3. U.S. Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, By Services, 2018 - 2030
  • 4.4. Bioanalytical Testing
    • 4.4.1. Bioanalytical Testing Market, 2018 to 2030 (USD Million)
    • 4.4.2. Clinical
      • 4.4.2.1. Clinical Market, 2018 to 2030 (USD Million)
    • 4.4.3. Non- Clinical
      • 4.4.3.1. Non- Clinical Market, 2018 to 2030 (USD Million)
  • 4.5. Method Development and Validation
    • 4.5.1. Method Development and Validation Market, 2018 to 2030 (USD Million)
    • 4.5.2. Extractable and Leachable
      • 4.5.2.1. Extractable and Leachable Market, 2018 to 2030 (USD Million)
    • 4.5.3. Impurity Method
      • 4.5.3.1. Impurity Method Market, 2018 to 2030 (USD Million)
    • 4.5.4. Technical Consulting
      • 4.5.4.1. Technical Consulting Market, 2018 to 2030 (USD Million)
    • 4.5.5. Other Method Validation Services
      • 4.5.5.1. Other Method Validation Services Market, 2018 to 2030 (USD Million)
  • 4.6. Stability Testing
    • 4.6.1. Stability Testing Market, 2018 to 2030 (USD Million)
    • 4.6.2. Drug Substance
      • 4.6.2.1. Drug Substance Market, 2018 to 2030 (USD Million)
    • 4.6.3. Stability Indicating Method Validation
      • 4.6.3.1. Stability Indicating Method Validation Market, 2018 to 2030 (USD Million)
    • 4.6.4. Accelerated Stability Testing
      • 4.6.4.1. Accelerated Stability Testing Market, 2018 to 2030 (USD Million)
    • 4.6.5. Photostability Testing
      • 4.6.5.1. Photostability Testing Market, 2018 to 2030 (USD Million)
    • 4.6.6. Other Stability Testing Methods
      • 4.6.6.1. Other Stability Testing Methods Market, 2018 to 2030 (USD Million)
  • 4.7. Other Testing Services
    • 4.7.1. Other Testing Services Market, 2018 to 2030 (USD Million)

Chapter 5. U.S. Pharmaceutical Analytical Testing Outsourcing Market: End Use Estimates & Trend Analysis

  • 5.1. U.S. Pharmaceutical Analytical Testing Outsourcing Market, By End Use: Segment Dashboard
  • 5.2. U.S. Pharmaceutical Analytical Testing Outsourcing Market, By End Use: Movement Analysis
  • 5.3. U.S. Pharmaceutical Analytical Testing Outsourcing Market Estimates & Forecasts, By End Use, 2018 - 2030
  • 5.4. Pharmaceutical Companies
    • 5.4.1. Pharmaceutical Companies Market, 2018 to 2030 (USD Million)
  • 5.5. Biopharmaceutical Companies
    • 5.5.1. Biopharmaceutical Companies Market, 2018 to 2030 (USD Million)
  • 5.6. Contract Research Organizations
    • 5.6.1. Contract Research Organizations Market, 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Market Participant Categorization
    • 6.1.1. Innovators
    • 6.1.2. Market Leaders
    • 6.1.3. Emerging Players
    • 6.1.4. Company Market Share Analysis, 2024
  • 6.2. Company Profiles
    • 6.2.1. West Pharmaceutical Services, Inc.
      • 6.2.1.1. Company Overview
      • 6.2.1.2. Financial Performance
      • 6.2.1.3. Service Benchmarking
      • 6.2.1.4. Strategic Initiatives
    • 6.2.2. SGS SA
      • 6.2.2.1. Company Overview
      • 6.2.2.2. Financial Performance
      • 6.2.2.3. Service Benchmarking
      • 6.2.2.4. Strategic Initiatives
    • 6.2.3. Eurofins Scientific
      • 6.2.3.1. Company Overview
      • 6.2.3.2. Financial Performance
      • 6.2.3.3. Service Benchmarking
      • 6.2.3.4. Strategic Initiatives
    • 6.2.4. Pace Analytical Services Llc
      • 6.2.4.1. Company Overview
      • 6.2.4.2. Financial Performance
      • 6.2.4.3. Service Benchmarking
      • 6.2.4.4. Strategic Initiatives
    • 6.2.5. Intertek Group PLC
      • 6.2.5.1. Company Overview
      • 6.2.5.2. Financial Performance
      • 6.2.5.3. Service Benchmarking
      • 6.2.5.4. Strategic Initiatives
    • 6.2.6. Pharmaceutical Product Development, LLC.
      • 6.2.6.1. Company Overview
      • 6.2.6.2. Financial Performance
      • 6.2.6.3. Service Benchmarking
      • 6.2.6.4. Strategic Initiatives
    • 6.2.7. Wuxi Apptec, Inc.
      • 6.2.7.1. Company Overview
      • 6.2.7.2. Financial Performance
      • 6.2.7.3. Service Benchmarking
      • 6.2.7.4. Strategic Initiatives
    • 6.2.8. Boston Analytical
      • 6.2.8.1. Company Overview
      • 6.2.8.2. Financial Performance
      • 6.2.8.3. Service Benchmarking
      • 6.2.8.4. Strategic Initiatives
    • 6.2.9. Charles River Laboratories International, Inc.
      • 6.2.9.1. Company Overview
      • 6.2.9.2. Financial Performance
      • 6.2.9.3. Service Benchmarking
      • 6.2.9.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 1 List of Abbreviations
  • Table 2 U.S. Pharmaceutical Analytical Testing Outsourcing Market, by Services, 2018 - 2030 (USD Million)
  • Table 3 U.S. Pharmaceutical Analytical Testing Outsourcing Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 U.S. Pharmaceutical Analytical Testing Outsourcing Market revenue, 2018 - 2030 (USD Million)
  • Fig. 10 U.S. Pharmaceutical Analytical Testing Outsourcing Market snapshot
  • Fig. 11 U.S. Pharmaceutical Analytical Testing Outsourcing Market driver impact
  • Fig. 12 U.S. Pharmaceutical Analytical Testing Outsourcing Market restraint impact
  • Fig. 13 U.S. Pharmaceutical Analytical Testing Outsourcing Services Key Takeaways (USD Million)
  • Fig. 14 U.S. Pharmaceutical Analytical Testing Outsourcing Market: Services movement analysis
  • Fig. 15 Bioanalytical Testing Market, 2018 - 2030 (USD Million)
  • Fig. 16 Clinical Market, 2018 - 2030 (USD Million)
  • Fig. 17 Non- Clinical Market, 2018 - 2030 (USD Million)
  • Fig. 18 Method Development and Validation Market, 2018 - 2030 (USD Million)
  • Fig. 19 Extractable and Leachable Market, 2018 - 2030 (USD Million)
  • Fig. 20 Impurity Method Market, 2018 - 2030 (USD Million)
  • Fig. 21 Technical Consulting Market, 2018 - 2030 (USD Million)
  • Fig. 22 Other Method Validation Services Market, 2018 - 2030 (USD Million)
  • Fig. 23 Stability Testing Market, 2018 - 2030 (USD Million)
  • Fig. 24 Drug Substance Market, 2018 - 2030 (USD Million)
  • Fig. 25 Stability Indicating Method Validation Market, 2018 - 2030 (USD Million)
  • Fig. 26 Accelerated Stability Testing Market, 2018 - 2030 (USD Million)
  • Fig. 27 Photostability Testing Market, 2018 - 2030 (USD Million)
  • Fig. 28 Other Stability Testing Methods Market, 2018 - 2030 (USD Million)
  • Fig. 29 Other Testing Services Market, 2018 - 2030 (USD Million)
  • Fig. 30 U.S. Pharmaceutical Analytical Testing Outsourcing Market End Use key takeaways (USD Million)
  • Fig. 31 U.S. Pharmaceutical Analytical Testing Outsourcing Market: End Use movement analysis
  • Fig. 32 Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
  • Fig. 33 Biopharmaceutical Companies Market, 2018 - 2030 (USD Million)
  • Fig. 34 Contract Research Organizations Market, 2018 - 2030 (USD Million)
  • Fig. 35 Market participant categorization